Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Reem H Elbekai"'
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92832 (2014)
In preparation for testing the safety of using serotype 2 recombinant adeno-associated vector, encoding Aquaporin-1 to treat radiation-induced salivary gland damage in a phase 1 clinical trial, we conducted a 13 week GLP biodistribution and toxicolog
Externí odkaz:
https://doaj.org/article/570388e5bbaa40e0a7342973957c7332
Autor:
Melissa D. Denton, Tom J. Vidmar, Reem H. Elbekai, John Martineck, Caren Brown, Peter C. Mann, Madhav G. Paranjpe, Marie McKeon
Publikováno v:
International Journal of Toxicology. 40:311-321
Our experience indicates that extrapolation of doses from the maximum tolerated doses (MTD) derived from 4-week dose range finding (DRF) studies conducted in CByB6F1 may overpredict tolerability and undermine utility of the high-dose groups in 26-wee
Autor:
Caren Brown, Peter C. Mann, Marie McKeon, Madhav G. Paranjpe, Jessica L. Belich, Dayauna R. Richardson, Reem H. Elbekai, Tom J. Vidmar
Publikováno v:
International Journal of Toxicology. 36:21-28
Three levels of nasal cavity sections (anterior, middle, and most posterior) are routinely examined as protocol required tissues in our 26-week carcinogenicity studies involving Tg.rasH2 mice. Exudative inflammation of the nasal cavity was noted in t
Autor:
Marie McKeon, Tom J. Vidmar, Madhav G. Paranjpe, Reem H. Elbekai, Dayauna R. Richardson, Peter C. Mann, Jessica L. Belich
Publikováno v:
International Journal of Toxicology. 36:29-34
Tg.rasH2 mice are predisposed to hemangiosarcomas. Following the spleen, the uterus is the second most commonly affected organ in the female mice. Female mice are also predisposed to spontaneous vascular proliferative lesions on the serosal surface o
Autor:
Reem H. Elbekai, Caren Brown, Marie McKeon, Madhav G. Paranjpe, Jessica L. Belich, Daniel J. Patrick, Peter C. Mann
Publikováno v:
Toxicologic pathology. 47(1)
This article presents the historical control data of spontaneous tumors in Tg.rasH2 published in 2013 (2004–2012) and compares and contrasts it to more recent data collected from 2013 to 2018, reporting differences in the average percentage inciden
Autor:
Reem H. Elbekai, Robert R. Young, Annette C. Rohr, Harshini Dinesdurage, Deborah M. Proctor, Mina Suh, Mark A. Harris, Chad M. Thompson
Publikováno v:
Environmental and Molecular Mutagenesis. 56:621-628
Exposure to high concentrations of hexavalent chromium [Cr(VI)] in drinking water was associated with an increased incidence of oral tumors in F344 rats in a 2-year cancer bioassay conducted by the National Toxicology Program. These tumors primarily
Autor:
Robert R. Young, Annette C. Rohr, Reem H. Elbekai, Mina Suh, Deborah M. Proctor, Harshini Dinesdurage, Chad M. Thompson
Publikováno v:
Environmental and Molecular Mutagenesis. 56:629-636
The Big Blue® (BB) in vivo mutation assay uses transgenic rodents to measure treatment-induced mutations in virtually any tissue. The BB assay can be conducted in rats or mice and is ideal for investigating tissue-specific mutagenic mode of action o
Autor:
Marie E. McKeon, Reem H. Elbekai, Gordon C. Hard, John C. Seely, Jessica L. Belich, Madhav G. Paranjpe, Peter C. Mann
Publikováno v:
Toxicologic Pathology. 44:633-635
We report renal tubular adenomas and a carcinoma in 26-week Tg.rasH2 mouse carcinogenicity studies, which have not been reported to date either at our facility or in other published data. However, during the year 2014, renal tubular tumors were prese
Autor:
Tom J. Vidmar, Reem H. Elbekai, Marie McKeon, Madhav G. Paranjpe, Jessica L. Belich, Caren Brown
Publikováno v:
International journal of toxicology. 36(4)
Our recent retrospective analysis of data, collected from 29 Tg.rasH2 mouse carcinogenicity studies, determined how successful the strategy of choosing the high dose for the 26-week studies was based on the estimated maximum tolerated dose (EMTD) der
Publikováno v:
Toxicologic Pathology. 43:611-620
High doses in Tg.rasH2 carcinogenicity studies are usually set at the maximum tolerated dose (MTD), although this dose selection strategy has not been critically evaluated. We analyzed the body weight gains (BWGs), mortality, and tumor response in co